Medical Devices DECODED
Previous edition: 27 Mar 2024
Share article
Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now
Cleerly touts new data for AI cardiovascular software
The AI-QCT ISCHEMIA software uses AI to analyse atherosclerosis and blood vessel shapes from CCTA images.
Digital healthcare company Cleerly has announced that positive data from two studies investigating its AI-QCT ISCHEMIA software device has been published.
Cleerly’s ISCHEMIA software device is an AI-powered tool that uses quantitative coronary computed tomography (QCT) angiography to diagnose coronary ischemia, a condition where there is reduced blood flow to the heart due to narrowed or blocked coronary arteries.
The device uses AI to analyse atherosclerosis and blood vessel shapes from patients’ coronary computed tomography angiography (CCTA) images.
The data, published in the Journal of the American College of Cardiology: Cardiovascular Imaging, is from two studies, CREDENCE (NCT02173275) and PACIFIC-1 (NCT01521468). The tool was developed and tested on patients with suspected stable coronary artery disease who underwent various heart imaging tests.
In the studies, the AI-QCT ISCHEMIA model showed strong diagnostic accuracy with AUC (area under the curve) values of 0.80 in the CREDENCE validation cohort and 0.85 in the PACIFIC-1 cohort. It outperformed other methods such as fractional flow reserve by CT (FFRcT), myocardial perfusion imaging (MPI), and positron emission tomography (PET). A positive result from the software was associated with a significantly higher risk of major adverse cardiovascular events (MACE).
Cleerly’s US Food and Drug Administration (FDA)-cleared technology comprises more than two dozen AI and machine learning algorithms. These were designed to recognise signs of heart disease based on more than ten million images from over 40,000 patients gathered during landmark, multi-centre clinical trials in a 15-year period.
When used in conjunction with Cleerly's LABS software, AI-QCT ISCHEMIA can assess for atherosclerosis, stenosis and ischemia, as per the 26 March press release.
In the announcement accompanying the data, Cleerly’s chief medical officer James Earls said: “These promising findings offer the possibility of a novel care paradigm for symptomatic coronary artery disease evaluation that performs comprehensive analysis of atherosclerosis, stenosis and ischemia from a single non-invasive CCTA test, which may offer the benefit of guiding clinical decision making for both coronary revascularisation and medical therapy."
In 2021, Cleerly teamed up with Canon Medical to integrate Canon’s AI-based CT technology with Cleerly’s digital pathway solution to evaluate coronary artery disease.
Latest news
Explainer: IVF access in Alabama - what comes next?
On 16 February the Alabama supreme court ruled that embryos used by IVF facilities constitute living children in a decision that has sent the state-wide industry into crisis.
Implantica gears up for FDA approval of acid reflux device
Implantica has submitted the first module of the PMA application for RefluxStop, with subsequent modules planned for submission in the next six months.
Avicenna.AI wins two FDA clearances for AI tools in CT scans
The FDA clears two algorithms for incidental pulmonary embolism detection and stroke severity assessment.
Endostart bags FDA 510(k) clearance for magnetic colonoscopy device
According to GlobalData’s Medical Intelligence Centre, the global colonoscope market is forecast to grow beyond $4.4bn by the end of 2030.
Wipro GE Healthcare plans $959m investment in India to boost production
Wipro GE plans to produce PET CT Discovery IQ diagnostic scan devices for export to 15 countries.
FDA issues clearance to Calyxo's redesigned CVAC System
This new system has already been used in over 50 procedures, receiving positive feedback from both patients and physicians.
In our previous edition
Medical Devices Decoded
Abbott's insertable cardiac monitor receives CE Mark
26 Mar 2024
Medical Devices Decoded
FDA issues 510(k) clearance for RedDrop Dx's blood collection device
25 Mar 2024
Medical Devices Decoded
USPTO backs Medtronic in patent infringement case against Axonics
22 Mar 2024
Newsletters in other sectors
Aerospace, Defence & Security
Automotive
Banking & Payments
Construction
Medical Devices
Travel and Tourism
Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer